CONMED | CNMD - Ebitda

Stock Price
53.67
Daily Change
-1.30 -2.36%
Monthly
5.11%
Yearly
-27.64%
Q3 Forecast
54.51

CONMED reported $56.31M in EBITDA for its fiscal quarter ending in June of 2025.




Ebitda Change Date
3M USD 1.45B 480M Jun/2025
Abbott USD 3.05B 870M Jun/2025
AtriCure USD 15.35M 16.22M Jun/2025
Avanos Medical USD -63900000 85.5M Jun/2025
Baxter International USD 325M 251M Mar/2025
Becton, Dickinson and Co. USD 1.47B 81M Jun/2025
Boston Scientific USD 1.36B 16M Mar/2025
CONMED USD 56.31M 16.81M Jun/2025
Cooper Companies USD 272.7M 5.8M Jul/2025
Dexcom USD 308.8M 115.1M Jun/2025
Edwards Lifesciences USD 411.3M 15.3M Mar/2025
Globus Medical USD 208.68M 44.48M Jun/2025
Hologic USD 334M 26.7M Jun/2025
Insulet USD 157.5M 47M Jun/2025
Integra LifeSciences USD -472218000 536.09M Jun/2025
Intuitive Surgical USD 898.7M 317.2M Jun/2025
J&J USD 7.88B 1.76B Mar/2025
Masimo USD 72M 17.3M Jun/2025
Medtronic USD 2.31B 400M Jul/2025
Merit Medical Systems USD 83.96M 10.65M Jun/2025
Olympus JPY 32.57B 38.11B Jun/2025
ResMed USD 540.03M 61.85M Jun/2025
Smith & Nephew USD 796M 48.8M Jun/2025
Steris USD 353.78M 33.81M Mar/2025
Stryker USD 1.46B 49M Jun/2025
Tandem Diabetes Care USD -1851000 28.33M Jun/2025
Teleflex USD 222.67M 27.85M Jun/2025
Zimmer Biomet Holdings USD 575.7M 26.1M Jun/2025